Adoptive T cell therapy is limited by antigen loss, poor tumor infiltration, and T cell exhaustion. Here, they report a nanoengineered system using anti-PD-1 antibody-conjugated ZIF-8 nanoparticles to effectively suppress pancreatic tumor growth in preclinical mice model.
- Ziqi Gan
- Jing Huang
- Zecong Xiao
